Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial - Zimmer, Lisa; Hassel, Jessica C.; Schadendorf, Dirk (The lancet, 2020)
Gesehen am 23.09.2020